Insufficient lymph node assessment in gastric adenocarcinoma.


Journal

Journal of the Egyptian National Cancer Institute
ISSN: 2589-0409
Titre abrégé: J Egypt Natl Canc Inst
Pays: England
ID NLM: 9424566

Informations de publication

Date de publication:
22 Oct 2019
Historique:
received: 10 09 2019
accepted: 13 09 2019
entrez: 7 5 2020
pubmed: 7 5 2020
medline: 30 10 2020
Statut: epublish

Résumé

This study aimed to investigate the sufficient (≥ 16) lymph node assessment in 449 patients with gastric adenocarcinoma and literature review. Four hundred and forty-nine patients with pathologically confirmed locoregional invasive gastric adenocarcinoma from 2004 to 2013 were included. A standard surgical resection was performed for all the patients with (n = 16) or without (n = 433) neoadjuvant treatment. In this study, 301 men and 148 women with a median age of 58 (range 21-88) years were included. The median total numbers of examined lymph nodes were 9 (range 0-55). Ninety-five patients (21.2%) had adequate (≥ 16) lymph node examination, and 70 patients (15.6%) had no examined lymph nodes. In univariate analysis, total or near total gastrectomy (P <  0.001), advanced node stage (P < 0.001), primary tumor size > 6 cm (P < 0.001), and the presence of perineural invasion (P = 0.039) were associated with more average number of examined lymph nodes. On multivariate analysis, node stage (P < 0.001) and type of surgery (P = 0.008) were independent predictive factors. In this study, approximately one in five patients with gastric adenocarcinoma had sufficient lymph node assessment. More studies are suggested for identifying a true inadequate lymph node dissection from insufficient lymph node assessment.

Sections du résumé

BACKGROUND BACKGROUND
This study aimed to investigate the sufficient (≥ 16) lymph node assessment in 449 patients with gastric adenocarcinoma and literature review.
METHODS METHODS
Four hundred and forty-nine patients with pathologically confirmed locoregional invasive gastric adenocarcinoma from 2004 to 2013 were included. A standard surgical resection was performed for all the patients with (n = 16) or without (n = 433) neoadjuvant treatment.
RESULTS RESULTS
In this study, 301 men and 148 women with a median age of 58 (range 21-88) years were included. The median total numbers of examined lymph nodes were 9 (range 0-55). Ninety-five patients (21.2%) had adequate (≥ 16) lymph node examination, and 70 patients (15.6%) had no examined lymph nodes. In univariate analysis, total or near total gastrectomy (P <  0.001), advanced node stage (P < 0.001), primary tumor size > 6 cm (P < 0.001), and the presence of perineural invasion (P = 0.039) were associated with more average number of examined lymph nodes. On multivariate analysis, node stage (P < 0.001) and type of surgery (P = 0.008) were independent predictive factors.
CONCLUSION CONCLUSIONS
In this study, approximately one in five patients with gastric adenocarcinoma had sufficient lymph node assessment. More studies are suggested for identifying a true inadequate lymph node dissection from insufficient lymph node assessment.

Identifiants

pubmed: 32372269
doi: 10.1186/s43046-019-0004-1
pii: 10.1186/s43046-019-0004-1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2

Auteurs

Nezhat Khanjani (N)

Department of Radiation Oncology, Shiraz University of Medical Sciences, Shiraz, Iran.

Sepideh Mirzaei (S)

Department of Radiation Oncology, Shiraz University of Medical Sciences, Shiraz, Iran.

Hamid Nasrolahi (H)

Department of Radiation Oncology, Shiraz University of Medical Sciences, Shiraz, Iran.

Seyed Hasan Hamedi (SH)

Department of Radiation Oncology, Shiraz University of Medical Sciences, Shiraz, Iran.

Ahmad Mosalaei (A)

Shiraz Institute for Cancer Research, Medical School, Shiraz University of Medical Sciences, Shiraz, Iran.

Shapour Omidvari (S)

Breast Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Niloofar Ahmadloo (N)

Department of Radiation Oncology, Shiraz University of Medical Sciences, Shiraz, Iran.

Mansour Ansari (M)

Breast Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Fatemeh Sobhani (F)

Department of Radiation Oncology, Shiraz University of Medical Sciences, Shiraz, Iran.

Mohammad Mohammadianpanah (M)

Colorectal Research Center, Shiraz University of Medical Sciences, Shiraz, 71936, Iran. mohpanah@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH